intestinal FABP protein (ab115502)
Constituents: 0.29% Sodium chloride, 0.69% Phosphate Buffer
- Pathways and Processes
- Metabolic signaling pathways
- Lipid and lipoprotein metabolism
- Fatty acids
Our Abpromise guarantee covers the use of ab115502 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|SDS-PAGE||SDS-PAGE: Use at an assay dependent concentration.|
|WB||WB: Use at an assay dependent dilution.|
|ELISA||ELISA: Use at an assay dependent dilution.|
- FABP 2FABP2FABPI
- FABPI_HUMANFatty acid binding proteinFatty acid binding protein 2 intestinalFatty acid binding protein intestinalFatty acid-binding proteinFatty acid-binding protein 2I FABPI-FABPIFABPintestinalIntestinal fatty acid binding protein 2Intestinal-type fatty acid-binding proteinMGC133132OTTHUMP00000163925
intestinal FABP protein images
14% SDS-PAGE showing ab115502
Lane 1: M.W. marker – 14, 21, 31, 45, 66, 97 kDa
Lane 2: reduced and boiled sample, 5µg/lane.
Lane 3: non-reduced and non-boiled sample, 5µg/lane.
References for intestinal FABP protein (ab115502)
ab115502 has not yet been referenced specifically in any publications.